Drug Safety Labeling Changes - March  2012

Email bookmark
Font : A-A+

Food and Drug Administration (FDA) announces important safety label changes for prescription drugs almost every month. By implementing the label changes the FDA warns a physician of new side- effects, adverse reactions, contra-indications and precautions necessary for a drug. This information is important for safe practice of medicine.

Key to Label Sections

  • C - Contraindications
  • W - Warnings
  • P - Precautions
  • AR - Adverse Reactions

Drug Name Sections Modified
C W P AR
Abacavir - - - -
Amphotericin B - -
Atazanavir - -
Azithromycin - -
Belimumab -
Bimatoprost - - -
Candesartan cilexetil hydrochlorothiazide - -
Citalopram - -
Darifenacin - -
Desvenlafaxine - - -
Ertapenem - - -
Furosemide - - -
Gadobenate- Dimeglumine -
Galantamine - - - -
Itraconazole
Ketamine - - -
Latanoprost - - -
Lenalidomide - -
Lidocaine - -
Lisinopril - -
Meloxicam - - -
Mitoxantrone - - - -
Naratriptan - - -
Octreotide - - -
Olmesartan - -
Oxybutynin Hydrochloride - - -
Pazopanib -
Repaglinide - - -
Repaglinide and Metformin - - -
Saxagliptin and Metformin - -
Sitagliptin - -
Sitagliptin-Metformin - -
Sumatriptan - - -
Sumatriptan Succinate and Naproxen Sodium - - -
Telaprevir - -
Telmisartan and Amlodipine - -
Zestoretic (lisinopril/hydrochlorothiazide) Tablets - -
Zoledronic Acid -

2016 - Monthly Summary Report for Drug Label Changes

2015 - Monthly Summary Report for Drug Label Changes

2014 - Monthly Summary Report for Drug Label Changes

2013 - Monthly Summary Report for Drug Label Changes

2012 - Monthly Summary Report for Drug Label Changes

Buy Medication (Drug) at Concessional Price from India

Drugs A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Drugs Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook